Blue Owl Capital Holdings »

Immix Biopharma shares owned by Blue Owl Capital Holdings

Quarter-by-quarter ownership of Immix Biopharma (IMMX) shares owned by Blue Owl Capital Holdings from 13F filings

Historical chart of Blue Owl Capital Holdings investment in Immix Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Immix Biopharma held by Blue Owl Capital Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immix Biopharma by Blue Owl Capital Holdings

Quarter filed Position value Share count Share price at filing
2025-12-31 $5.2M 986k 5.23

More positions owned by Blue Owl Capital Holdings

Engene Holdings (ENGN)
Nuveen Churchill Direct Lend Com Shs (NCDL)
Owl Rock Capital Corporation (OBDC)
Larimar Therapeutics (LRMR)
Cullinan Oncology (CGEM)
Compass Therapeutics (CMPX)
Holley (HLLY)
Context Therapeutics (CNTX)
Conduent Incorporate (CNDT)
Repare Therapeutics Ord
Civeo Corp Cda Com New (CVEO)
Sagimet Biosciences Com Ser A (SGMT)
Eyepoint Com New (EYPT)
Procore Technologies (PCOR)
Dell Technologies CL C (DELL)

View all positions for Blue Owl Capital Holdings

Top funds holding Immix Biopharma

Saturn V Capital Management
Eventide Asset Management
Marshall Wace
Vanguard Group
Logos Global Management
Bleichroeder
Blue Owl Capital Holdings
Franklin Resources
Susquehanna International
Renaissance Technologies
Geode Capital Management
KVP Capital Advisors
Goldman Sachs Group
Jane Street
LGT Fund Management

View all funds holding Immix Biopharma